Biopharmaceutical company
HR 3938/S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization. HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers. P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
INTRA-CELLULAR THERAPIES, INC.
430 East 29th Street, Suite 900, New York, NY, 10016, US
ANDREW SPERLING ANDREW SPERLING ANDREW SPERLING